Blackthorn (LSE:BRL)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Blackthorn Charts. Click Here for more Blackthorn Charts.](/p.php?pid=staticchart&s=L%5EBRL&p=8&t=15)
MONTVALE, N.J., March 28 /PRNewswire/ --
Christine A. Mundkur, Esq.
Chief Executive Officer,
Barr Laboratories, Inc.
-- In this newly created position, Mundkur has responsibility for Barr's
global generics business, including strategic planning, research and
development, regulatory affairs, operations, quality, and sales and
marketing. Under her leadership, Barr Laboratories will continue to
support the proprietary business in the areas of formulation,
regulatory affairs, and product supply.
-- Most recently served as Executive Vice President, Global Quality,
Safety and Regulatory Affairs, with responsibility for leading the
Company's Global Quality, Safety, PK/BE and Regulatory Affairs
Operations.
-- Barr: 15 years
* Joined Barr In 1993 As An Associate Counsel.
* Named Director Of Regulatory Affairs and Regulatory Counsel In
1997.
* Promoted to Vice President, Quality And Regulatory Counsel In 1998.
* Promoted to Sr. Vice President Quality and Regulatory Counsel in
2001.
* Promoted to Executive Vice President In 2007.
-- Bachelor of Science in Chemistry from Saint Louis University.
-- Juris Doctorate from Saint Louis University School of Law.
G. Frederick Wilkinson
Chief Executive Officer,
Duramed Pharmaceuticals, Inc.
-- In this newly created position, Wilkinson has responsibility for all
functions related to product selection, clinical development, and sales
and marketing. He will also continue directing Barr's growing global
biologics development program and for providing the strategic direction
and coordination of the Company's global business development
activities for our generic, proprietary and biologics activities.
-- Most recently served as President and Chief Operating Officer of
Duramed Pharmaceuticals, Inc., the proprietary products subsidiary of
Barr Pharmaceuticals, Inc.
-- Barr: 2 years
* Joined Barr in 2006.
* Prior to joining Barr, Wilkinson served as Chief Executive Officer,
President and a member of the Board of Directors of Columbia
Laboratories.
* From 1996 to 2001, Wilkinson was Watson Pharmaceuticals' Chief
Operating Officer and Senior Vice-President.
* Prior to joining Watson, Wilkinson spent 16 years at Sandoz
Pharmaceutical Corporation in numerous senior managerial positions
of increasing responsibility.
-- M.B.A. from Capital University.
-- B.S. in Pharmacy from Ohio Northern University.
Michael J. Bogda
President and Chief Operating Officer,
Barr Laboratories, Inc.
-- In his new position, Bogda will continue to oversee all aspects of
Global Product Supply and has expanded responsibilities for Quality and
Pharma Chemicals. In addition to his operational oversight
responsibilities, Bogda will also participate in the Company's
budgeting, financial forecasting and capital management activities.
-- Most recently served as Executive Vice President, Global Product Supply
("GPS") with responsibility for managing the Company's GPS team,
including the operational areas of manufacturing, engineering,
distribution, order processing, packaging, validation and process
technical services, project management and supply chain.
-- Barr: 7 years
* Joined Barr in 2000 as Vice President of Validation and Technical
Services and held various positions of increasing responsibility
with the Company.
* 2001 Promoted to Senior Vice President, Manufacturing and
Engineering.
* 2007 Promoted to Executive Vice President, Global Product Supply.
* Prior to joining Barr, Bogda served as Vice President Operations
and Facility General Manager at Copley Pharmaceutical Inc. where
he managed the consolidation and integration of Copley's
manufacturing plants after the company's acquisition by Teva
Pharmaceuticals USA.
* Bogda served on the Executive Management Committee at Copley
Pharmaceuticals.
-- Master of Science in Chemical Engineering from Rutgers University
College of Engineering.
-- Master of Business Administration from the Wharton School.
Timothy B. Sawyer
Executive Vice President,
Global Generic Sales and Marketing,
Barr Laboratories, Inc.
-- As Executive Vice President, Global Generic Sales and Marketing
Operations, Timothy Sawyer has responsibility for the Company's generic
commercial operations for Europe/Rest of World ("ROW") and the U.S.
-- Most recently served as Barr's Senior Vice President of European
Commercial Development, with responsibility in the European and ROW
markets for all sales and marketing activities, including coordinating
business development activities among the country managers to enhance
Barr's product portfolio and increase profitability throughout the
European/ROW markets.
-- Barr: 15 years
* Joined Barr in 1993 as Manager, Sales Administration.
* Promoted to the position of Associate Director New Business
Development in 1996.
* Promoted to Director of Sales Administration and New Business
Development in 2000.
* Named Vice President in 2001.
* Promoted to Senior Vice President in November 2006.
* Prior to joining Barr, Sawyer was associated with the law firm of
Winston & Strawn.
-- Bachelors Degree from the University of Richmond.
DATASOURCE: Barr Pharmaceuticals, Inc.
CONTACT: Carol A. Cox of Barr Pharmaceuticals, Inc., +1-201-930-3720,
Web site: http://www.barrlabs.com/
Company News On-Call: http://www.prnewswire.com/comp/089750.html